# Chronic Kidney Disease Antidepressant Sertraline Trial

Study · id `cardio:ct-nct00946998` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT00946998](<https://clinicaltrials.gov/study/NCT00946998>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT00946998

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.

## Technical summary

Registry record NCT00946998. Randomized; quadruple masking; primary purpose treatment. Start 2010-02-08 (actual); primary completion 2016-11-23 (actual). Results posted on 2018-01-30.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 201 participants (enrolled count; ClinicalTrials.gov record NCT00946998, source copy `cardio:ctgov-nct00946998-2018-03-09`, retrieved 2026-10-26)
- Started: 2010-02-08 (actual) (ClinicalTrials.gov record NCT00946998, source copy `cardio:ctgov-nct00946998-2018-03-09`, retrieved 2026-10-26)
- Primary completion: 2016-11-23 (actual) (ClinicalTrials.gov record NCT00946998, source copy `cardio:ctgov-nct00946998-2018-03-09`, retrieved 2026-10-26)
- Completion: 2017-11 (actual) (ClinicalTrials.gov record NCT00946998, source copy `cardio:ctgov-nct00946998-2018-03-09`, retrieved 2026-10-26)
- Results first posted: 2018-01-30 (ClinicalTrials.gov record NCT00946998, source copy `cardio:ctgov-nct00946998-2018-03-09`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT00946998, source copy `cardio:ctgov-nct00946998-2018-03-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct00946998-2018-03-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Chronic Kidney Disease Antidepressant Sertraline Trial
- Acronym: CAST
- Condition: Chronic Kidney Disease
- Condition: Depression
- Intervention (Drug): Sertraline
- Intervention (Drug): placebo
- Lead sponsor: VA Office of Research and Development
- Lead sponsor class: FED
- Collaborator: University of Texas Southwestern Medical Center
- Collaborator class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: VA Office of Research and Development (`cardio:org-va-office-of-research-and-development`)
- Registry lists this organization as a collaborator: University of Texas Southwestern Medical Center (`cardio:org-university-of-texas-southwestern-medical-center`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial (`cardio:pubmed-29101402`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Depression and the Effect of Sertraline on Inflammatory Biomarkers in Patients with Nondialysis CKD (`cardio:pubmed-35368605`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: d70a1b1e5faadce18d17aa10c060cff49e275dd09a3f018530b30bd212b045bf
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
